Overview
Safety in plain terms
Generally tolerable; headache and GI upset appear.
Tolerability
Commonly reported effects
- Headache
- Gas
- Dark urine discoloration (benign reports)
Higher-risk contexts
Who should pause or get medical guidance first
- Hormone-sensitive cancers without oncology clearance
- Pregnancy
Polypharmacy
Interactions & cautions
- CYP substrates like tamoxifen and some psychiatric meds - disclose
Practical
Dose context (not a prescription)
Hormone-sensitive cancers require oncology gates.
Our editorial safety score is 68/100 - methodology and limitations are on the full hub page.
Verdict context
Published human data are thin for the loudest claims; enthusiasm is mostly ahead of proof.
Same ingredient, other questions
Focused pages for common searches about DIM (diindolylmethane). Each uses the same underlying evidence file with a different lens.
Explore further
A few hand-picked entry points around DIM (diindolylmethane): categories, answers to narrow questions, and comparisons.
Related ingredients
Ingredients we group near DIM (diindolylmethane) in our model - not interchangeable, but often read together.
- Psyllium husk78/100Strong support
Soluble fiber with strong evidence for constipation and as a lipid adjunct in some guideline discussions when taken with water.
- Omega-3 fatty acids77/100Promising
EPA/DHA support cardiovascular risk reduction contexts in some guidelines; supplements vary widely in quality and dose.
- Prebiotics76/100Strong support
Fibers and oligosaccharides that selectively feed commensal microbes; strongest human stories sit in IBS-style and regularity contexts.
Alternatives
Swaps people discuss alongside DIM (diindolylmethane) - still judge each ingredient on its own evidence.